AstraZeneca bets $247M AI can create a cancer-fighting antibody

Monday December 4, 2023. 11:35 PM , from TheRegister

Startup Absci will turn to its generative AI algorithms to design synthetic protein
Pharma giant AstraZeneca has signed a $247 million deal with Ai drug creation company Absci to develop an antibody designed to fight cancer.…

Read more at TheRegister

https://go.theregister.com/feed/www.theregister.com/2023/12/04/astrazeneca_absci_cancer/

Current Date

May, Sat 10 - 18:51 CEST